Treatment with statins might lead to an increase in statin-associated autoimmune diseases, notably myositis or other related myopathies, in the American Indian population.

Systemic use of antibiotics has long lasting effects on skin microbial communities, leading to the development and persistence of antibiotic resistance.

Nicotinamide riboside (NR) can be used as a potential adjunct to lupus treatment.

GMR biosensors can serve as a real-time diagnostic tool for clinical management of influenza infection.

The protocol describes in detail the mechanical and enzymatic dissociation of mononucleated cells from whole limb muscles and injured tibialis anterior (TA) muscles to isolate FAPs and MuSCs. Additionally, it describes an optimized method for culturing quiescent and activated FAPs and MuSCs.

The FOXM1 pathway is a novel regulator of NET formation during diabetic wound healing and can be used as a therapeutic target to promote healing in DFUs. Expression of TREM1 in neutrophils is less in DFUs.

Presence of co-existing anti-Sp4 autoantibodies identifies a subgroup of anti-TIF1γ-positive DM patients with lower cancer risk.

Anti-FHL1 autoantibodies in juvenile myositis is associated with V-sign rash on their chest and co-existing anti-Ro52 autoantibodies but not with adverse outcomes.

A derivative of itaconic acid, 4-octyl itaconate, inhibits immune dysregulation and organ damage in lupus mice.

NETs were detected in many organs of adult patients who died from COVID-19 complications. Compared with other SARS-CoV-2 strains, the Omicron variant was associated with decreased NET levels.